VI
TXG icon

Versor Investments’s 10x Genomics TXG Stock Holding History

Versor Investments’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-22,076
Closed -$256K – 913
2025
Q2 		$256K Buy
+22,076
New +$201K 0.05% 590
2024
Q4 		– Sell
-12,400
Closed -$280K – 983
2024
Q3 		$280K Sell
12,400
-800
-6% -$16.5K 0.04% 609
2024
Q2 		$257K Buy
13,200
+367
+3% +$9.61K 0.05% 581
2024
Q1 		$482K Buy
+12,833
New +$564K 0.1% 341
2023
Q4 		– Sell
-6,683
Closed -$276K – 866
2023
Q3 		$276K Sell
6,683
-3,276
-33% -$170K 0.06% 509
2023
Q2 		$556K Buy
+9,959
New +$539K 0.1% 232

Other funds holding TXG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Versor Investments's TXG Position: Q3 2025 in Review

Versor Investments sold out of 10x Genomics (TXG) in Q3 2025, closing a stake of 22,076 shares — an estimated $256K sold.

Versor Investments first reported a position in TXG in Q2 2023 and held it in 6 quarters. The position peaked at $556K in Q2 2023. 317 funds tracked by Wall St. Rank hold TXG as of Q3 2025.

  • Versor Investments reported no remaining 10x Genomics position as of Q3 2025 after selling out during the quarter.
  • Versor Investments sold 22,076 10x Genomics shares in Q3 2025, an estimated $256K.
  • Versor Investments first reported a position in 10x Genomics in Q2 2023 and held it in 6 quarters.
  • Versor Investments's 10x Genomics position peaked at $556K in Q2 2023.
  • 317 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2025.

Based on Versor Investments's 13F filing for Q3 2025, filed 6 Nov 2025.